Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries

European Heart Journal

4 November 2021
Organised by: Logo
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE Stroke Research Methodology HEART FAILURE Chronic Heart Failure OTHER PREVENTIVE CARDIOLOGY Risk Factors and Prevention VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure Valvular Heart Disease

Abstract

AbstractAims

Patients with cardiac disease are considered high risk for poor outcomes following hospitalization with COVID-19. The primary aim of this study was to evaluate heterogeneity in associations between various heart disease subtypes and in-hospital mortality.

Methods and results

We used data from the CAPACITY-COVID registry and LEOSS study. Multivariable Poisson regression models were fitted to assess the association between different types of pre-existing heart disease and in-hospital mortality. A total of 16 511 patients with COVID-19 were included (21.1% aged 66–75 years; 40.2% female) and 31.5% had a history of heart disease. Patients with heart disease were older, predominantly male, and often had other comorbid conditions when compared with those without. Mortality was higher in patients with cardiac disease (29.7%; n = 1545 vs. 15.9%; n = 1797). However, following multivariable adjustment, this difference was not significant [adjusted risk ratio (aRR) 1.08, 95% confidence interval (CI) 1.02–1.15; P = 0.12 (corrected for multiple testing)]. Associations with in-hospital mortality by heart disease subtypes differed considerably, with the strongest association for heart failure (aRR 1.19, 95% CI 1.10–1.30; P < 0.018) particularly for severe (New York Heart Association class III/IV) heart failure (aRR 1.41, 95% CI 1.20–1.64; P < 0.018). None of the other heart disease subtypes, including ischaemic heart disease, remained significant after multivariable adjustment. Serious cardiac complications were diagnosed in <1% of patients.

Conclusion

Considerable heterogeneity exists in the strength of association between heart disease subtypes and in-hospital mortality. Of all patients with heart disease, those with heart failure are at greatest risk of death when hospitalized with COVID-19. Serious cardiac complications are rare during hospitalization.

Contributors

Author

A Uijl
A Uijl

Author

A Schut
A Schut

Author

R M Bell
R M Bell

Author

N C Lea
N C Lea

Author

J Schaap
J Schaap

Author

C Anning
C Anning

Author

C Ball
C Ball

Author

M Bianco
M Bianco

Author

W L Bor
W L Bor

Author

G Captur
G Captur

Author

M Caputo
M Caputo

Author

P Dark
P Dark

Author

S Dolff
S Dolff

Author

A G Er
A G Er

Author

F Hanses
F Hanses

Author

E Hellou
E Hellou

Author

A D Hilt
A D Hilt

Author

M Hower
M Hower

Author

B Jensen
B Jensen

Author

D Lomas
D Lomas

Author

M Maarse
M Maarse

Author

M Magro
M Magro

Author

U Merle
U Merle

Author

A J Moss
A J Moss

Author

E Parker
E Parker

Author

C Piepel
C Piepel

Author

S Prasad
S Prasad

Author

J Redón
J Redón

Author

C Riedel
C Riedel

Author

S Rieg
S Rieg

Author

R Salah
R Salah

Author

E Saneei
E Saneei

Author

M Saxena
M Saxena

Author

J Seelig
J Seelig

Author

R A Tio
R A Tio

Author

J Trauth
J Trauth

Author

I Voigt
I Voigt

Author

L Walter
L Walter

Author

E Wierda
E Wierda

Author

K Wille
K Wille

Author

M Worm
M Worm

Author

K W Wu
K W Wu

Author

R Zaal
R Zaal

Author

R Ahmed
R Ahmed

Author

M Bontje
M Bontje

Author

M Bos
M Bos

Author

L Bosch
L Bosch

Author

B Cosyns
B Cosyns

Author

F Dormal
F Dormal

Author

A Guclu
A Guclu

Author

A Habib
A Habib

Author

K K Kui
K K Kui

Author

H Vial
H Vial

Author

A M Wils
A M Wils

Author

ESC 365 is supported by